~4 spots leftby Mar 2026

Exercise for Metabolic Disorders

(Columbus Trial)

Recruiting in Palo Alto (17 mi)
Overseen bySteven R Smith, MD
Age: 18 - 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Translational Research Institute for Metabolism and Diabetes, Florida
No Placebo Group
Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?The purpose of this study is to collect data to help researchers identify factors, such as certain proteins or genetic codes, that are secreted from muscle that are associated with the beneficial effects of exercise.

Eligibility Criteria

This trial is for healthy men and women aged 18-40 who don't have Type 2 Diabetes or significant diseases affecting the kidneys, heart, liver, lungs, or nerves. Participants must not use certain weight-affecting drugs and should be free from recent surgeries or conditions that affect blood flow. They can't smoke or consume alcohol/caffeine before tests.

Inclusion Criteria

I am between 18 and 40 years old and in good health.
Willing to stop alcohol and caffeine consumption for 48 hours preceding each blood draw

Exclusion Criteria

Abnormal resting ECG
Unwilling or unable to abstain from caffeine or alcohol 48 hours prior to metabolic rate measurements
Metal objects that would interfere with the measurement of body composition /magnetic resonance spectroscopy such as implanted rods, surgical clips, etc
+27 more

Participant Groups

The study aims to identify muscle-secreted factors that contribute to exercise's benefits by analyzing participants' responses to physical activity. Researchers will look for proteins and genetic markers linked with improved lipid oxidation.
3Treatment groups
Experimental Treatment
Active Control
Group I: Group 1 - Regular exerciseExperimental Treatment1 Intervention
Alternate interval training and aerobic training and exercise
Group II: Group 2 - Athlete exerciseActive Control1 Intervention
Athletes are not given any intervention
Group III: Group 3 - Obese No ExerciseActive Control1 Intervention
The Obese group will not receive intervention

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Translational Research Institute for Metabolism and DiabetesOrlando, FL
Loading ...

Who Is Running the Clinical Trial?

Translational Research Institute for Metabolism and Diabetes, FloridaLead Sponsor
AdventHealth Translational Research InstituteLead Sponsor
Sanford-Burnham Medical Research InstituteCollaborator
TakedaIndustry Sponsor

References